Ventricular Tachycardia (VT) is a cardiac arrhythmia characterized by a rapid and regular heartbeat originating in the heart's lower chambers, the ventricles. In VT, the heart beats at a significantly faster rate than normal, disrupting its regular rhythm. This condition poses serious health risks as it may lead to inadequate blood flow to the body and, in severe cases, progress to more life-threatening arrhythmias. Ventricular Tachycardia can occur in individuals with pre-existing heart conditions, such as coronary artery disease or structural heart abnormalities, but it can also manifest in those with otherwise healthy hearts. Prompt diagnosis and management are crucial to prevent complications and improve patient outcomes, often involving anti-arrhythmic medications, catheter ablation, or, in severe cases, implantable cardioverter-defibrillator (ICD) placement. Regular monitoring and collaboration between healthcare professionals play a vital role in effectively addressing Ventricular Tachycardia and ensuring the well-being of affected individuals.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China